𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glucocorticoids increase CD4+CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis

✍ Scribed by M. Braitch; S. Harikrishnan; R. A. Robins; C. Nichols; A. J. Fahey; L. Showe; C. S. Constantinescu

Book ID
109338858
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
195 KB
Volume
119
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Secondary progressive in contrast to rel
Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression
✍ Koen Venken; Niels Hellings; Karen Hensen; Jean-Luc Rummens; Robert Medaer; Mari πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 645 KB

## Abstract Accumulating evidence indicates an immunosuppressive role for CD4^+^CD25^+^ regulatory T cells (Tregs) in autoimmune diseases. Although an impaired Treg function in patients with relapsing‐remitting multiple sclerosis (RR‐MS) has been reported recently, no information is available so fa

The regulation of Foxp3 expression in re
The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: Multiple pathways on the road
✍ Lianjun Zhang; Yong Zhao πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 160 KB πŸ‘ 1 views

## Abstract Regulatory T cells (Treg cells) have been well documented to have a crucial physiological role in preventing the development of autoimmune diseases and keeping self‐tolerance. Foxp3, a recently identified member of the forkhead transcription factors, serves as a master regulator for the